AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 CelsionAridis PharmaceuticalsCV SciencesDiaMedica TherapeuticsVaccinex
SymbolNASDAQ:CLSNNASDAQ:ARDSOTCMKTS:CVSINASDAQ:DMACNASDAQ:VCNX
Price Information
Current Price$2.78$6.75$0.78$4.83$3.64
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score0.71.31.91.12.0
Analysis Score0.03.53.33.53.5
Community Score2.82.32.72.22.0
Dividend Score0.00.00.00.00.0
Ownership Score0.00.03.00.04.0
Earnings & Valuation Score0.60.60.60.00.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price TargetN/A$16.60$3.35$14.50$22.00
% Upside from Price TargetN/A145.93% upside329.54% upside200.21% upside504.40% upside
Trade Information
Market Cap$83.68 million$62.64 million$77.87 million$70.55 million$60.44 million
Beta2.450.040.352.811.21
Average Volume755,10610,504975,56157,22740,964
Sales & Book Value
Annual Revenue$500,000.00$1.02 million$53.70 million$500,000.00$520,000.00
Price / Sales162.6759.051.45136.58116.52
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.63 per share$0.41 per share$0.29 per share$0.64 per share($0.15) per share
Price / Book4.4116.462.697.55-24.27
Profitability
Net Income$-16,850,000.00$-29,680,000.00$-16,610,000.00$-10,650,000.00$-31,860,000.00
EPS($0.91)($3.51)($0.17)($0.89)($2.47)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-3,908.00%N/A-26.31%N/A-4,740.03%
Return on Equity (ROE)-120.14%-538.27%-40.55%-92.84%-2,277.96%
Return on Assets (ROA)-48.44%-112.25%-23.71%-83.19%-436.90%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.53%N/A0.36%0.01%N/A
Current Ratio2.54%1.03%2.17%15.15%0.64%
Quick Ratio2.54%1.03%1.46%15.15%0.64%
Ownership Information
Institutional Ownership Percentage8.46%1.07%N/A20.68%8.56%
Insider Ownership Percentage9.30%20.85%14.60%12.60%68.60%
Miscellaneous
Employees292578944
Shares Outstanding29.26 million8.92 million99.85 million14.14 million16.65 million
Next Earnings Date8/12/2020 (Estimated)8/10/2020 (Estimated)8/4/2020 (Estimated)8/11/2020 (Estimated)8/12/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.